1-6 of 6
Arta Dreimane
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

No Increased Prevalence of Malignancies Among First-Degree Relatives of Patients with Chronic Myeloid Leukemia - Data from Population-Based Swedish Registries

Niklas Gunnarsson, MD, Martin Höglund, MD PhD, Leif Stenke, MD PhD, Fredrik Sandin, MSc, Magnus Bjorkholm, Arta Dreimane, MD PhD, Mats Lambe, MD PhD, Berit Markevärn, MD, Ulla Olsson-Strömberg, MD PhD, Hans Wadenvik, MD PhD, Johan Richter, MD, Anders Själander, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1896.
https://doi.org/10.1182/blood.V128.22.1896.1896
Published: 2016
Journal Articles

Effects of Dasatinib and Interferon-α Combination Treatment on the Immune System in CML

Mette Ilander, PhD, Hanna Lähteenmäki, MSc, Ulla Olsson-Stromberg, MD PhD, Jesper Stentoft, MD PhD, Johan Richter, MD, Perttu Koskenvesa, MD, Martin Höglund, MD PhD, Arta Dreimane, MD PhD, Kimmo Porkka, MD PhD, Tobias Gedde-Dahl, Björn T. Gjertsen, Franz X. Gruber, Leif Stenke, MD PhD, Kristina Myhr-Eriksson, MD, Berit Markevärn, MD, Anna Lubking, MD, Hanne Vestergaard, MD PhD, Lene Udby, MD, Ole Weis Bjerrum, MD, Henrik Hjorth-Hansen, MD PhD, Satu Mustjoki, MD PhD
Journal: Blood
Blood (2016) 128 (22): 627.
https://doi.org/10.1182/blood.V128.22.627.627
Published: 2016
Journal Articles

Safety and Efficacy of Addition of Pegylated Interferon alpha2b to Standard Dose Dasatinib in Newly Diagnosed Chronic Phase CML Patients

Henrik Hjorth-Hansen, MD PhD, Jesper Stentoft, Johan Richter, MD PhD, Perttu Koskenvesa, MD, Arta Dreimane, MD, Kimmo Porkka, MD PhD, Tobias Gedde-Dahl, MDPhD, Bjorn Gjertsen, MD PhD, Franz X. Gruber, MDPhD, Martin Hoglund, MD PhD, Anna Lubking, MD, Kristina Myhr-Eriksson, MD, Berit Markevärn, Hanne Vestergaard, MDPhD, Ole Weis Bjerrum, MDPhD, Leif Stenke, MDPhD, Satu Mustjoki, MD PhD, Ulla Stromberg, MDPhD
Journal: Blood
Blood (2015) 126 (23): 477.
https://doi.org/10.1182/blood.V126.23.477.477
Published: 2015
Journal Articles

Increased Prevalence of Prior Malignancies and Autoimmune Diseases in Patients Diagnosed with Chronic Myeloid Leukemia

Niklas Gunnarsson, MD, Martin Hoglund, MD PhD, Leif Stenke, MD PhD, Solveig Wallberg Jonsson, MD PhD, Fredrik Sandin, PhD, Magnus Bjorkholm, MD PhD, Arta Dreimane, MD PhD, Mats Lambe, MD PhD, Berit Markevarn, MD, Ulla Olsson-Stromberg, MD PhD, Hans Wadenvik, MD PhD, Johan Richter, MD PhD, Anders Sjalander, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1586.
https://doi.org/10.1182/blood.V126.23.1586.1586
Published: 2015
Journal Articles

Second Malignancies Following Treatment of Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era

Niklas Gunnarsson, MD, Stenke Leif, MD PhD, Martin Höglund, MD PhD, Fredrik Sandin, PhD, Magnus Björkholm, MD PhD, Arta Dreimane, MD PhD, Mats Lambe, MD PhD, Berit Markevärn, MD, Ulla Olsson-Strömberg, MD PhD, Johan Richter, MD PhD, Hans Wadenvik, MD PhD, Jonas Wallvik, MD PhD, Anders Själander, MD PhD
Journal: Blood
Blood (2014) 124 (21): 154.
https://doi.org/10.1182/blood.V124.21.154.154
Published: 2014
Journal Articles

Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry

Martin Höglund, Fredrik Sandin, Karin Hellström, Mats Björeman, Magnus Björkholm, Mats Brune, Arta Dreimane, Marja Ekblom, Sören Lehmann, Per Ljungman, Claes Malm, Berit Markevärn, Kristina Myhr-Eriksson, Lotta Ohm, Ulla Olsson-Strömberg, Anders Själander, Hans Wadenvik, Bengt Simonsson, Leif Stenke, Johan Richter
Journal: Blood
Blood (2013) 122 (7): 1284–1292.
https://doi.org/10.1182/blood-2013-04-495598
Published: 2013